Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000899140-21-000709
Filing Date
2021-11-04
Accepted
2021-11-04 17:11:56
Documents
2
Group Members
DANIEL S. LOEB

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D v102821a.htm SC 13D 61910
2 JOINT FILING AGREEMENT v102821b.htm EX-1 5164
  Complete submission text file 0000899140-21-000709.txt   68639
Mailing Address 55 HUDSON YARDS NEW YORK NY 10001
Business Address 55 HUDSON YARDS NEW YORK NY 10001 2127153880
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

EIN.: 133922602 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Subject) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92974 | Film No.: 211381101
SIC: 2834 Pharmaceutical Preparations